Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Non-cash Items (2018 - 2019)

X4 Pharmaceuticals (XFOR) has disclosed Non-cash Items for 2 consecutive years, with $489033.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Non-cash Items rose 164.34% year-over-year to $489033.0, compared with a TTM value of $489033.0 through Jun 2019, up 164.34%, and an annual FY2018 reading of $6.5 million, changed N/A over the prior year.
  • Non-cash Items was $489033.0 for Q2 2019 at X4 Pharmaceuticals, down from $556774.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $27.4 million in Q1 2018 and bottomed at $185000.0 in Q2 2018.